Stoke Therapeutics Inc (STOK)

R&D Expenses

$167.26M

TTM · Period ending: · USD

STOK logo

STOK R&D Expenses

Latest reported$167.26M
STOK TTM R&D Expenses ($8.37M → $167.26M)
High-resolution chart · PNG

STOK r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Stoke Therapeutics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
167,260,000
144,072,000
137,075,000
119,208,000
104,159,000
98,892,000
88,021,000
85,752,000
83,181,000
82,533,000
79,762,000
79,060,000
79,147,000
77,263,000
76,291,000
71,641,000
66,278,000
62,317,000
54,168,000
47,270,000
41,021,000
34,894,000
32,196,000
30,381,000
28,790,000
26,845,000
23,763,000
19,678,000
15,387,000
11,252,000
8,371,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.